Lead in breast milk and maternal bone turnover

Area of Science:

• Environmental Health
• Reproductive Health
• Toxicology

Background:

• Lead (Pb) exposure during reproduction is a concern due to potential effects on maternal and infant health.
• Bone turnover and loss can occur during the reproductive period, influenced by various physiological and environmental factors.
• Understanding the relationship between lead levels in breast milk and maternal bone health is crucial for assessing risks.

Purpose of the Study:

• To investigate the correlation between lead (Pb) levels in breast milk and maternal blood lead levels.
• To determine if breast milk lead levels are associated with bone loss or bone turnover in postpartum women.
• To assess the relationship between maternal bone mineral density changes and lead exposure during reproduction.

Main Methods:

• Prospective data collection from lactating and bottle-feeding women up to 12 months postpartum.
• Measurement of breast milk lead (Pb) using inductively coupled mass spectrometry.
• Assessment of maternal blood lead (Pb) via atomic absorption spectrophotometry, osteocalcin levels, and bone mineral density changes.

Main Results:

• Mean breast milk lead concentrations ranged from 4.3 to 6.1 ng/mL, while maternal blood lead levels were between 1.4 and 1.7 microg/dL.
• A 5.6% bone loss and significant bone turnover were correlated with breast milk lead levels.
• Maternal and breast milk lead values showed a modest correlation between 1 to 2 months postpartum.

Conclusions:

• Postpartum bone loss and bone turnover are associated with lead (Pb) levels found in breast milk.
• The study found no evidence that high maternal blood or breast milk lead concentrations pose a significant public health concern in the studied population.
• Further research may be warranted to fully elucidate the long-term implications of lead exposure via breast milk.